Adial Pharmaceuticals Enters Material Definitive Agreement
Ticker: ADIL · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1513525
| Field | Detail |
|---|---|
| Company | Adial Pharmaceuticals, Inc. (ADIL) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, filing
TL;DR
Adial Pharma signed a big deal, filing details on June 18th.
AI Summary
On June 16, 2025, Adial Pharmaceuticals, Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company also reported other events and filed financial statements and exhibits. The filing was made on June 18, 2025.
Why It Matters
This filing indicates a significant development for Adial Pharmaceuticals, potentially impacting its future operations and financial standing.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can carry significant risks and opportunities, the nature of which is not fully detailed in this initial filing.
Key Players & Entities
- Adial Pharmaceuticals, Inc. (company) — Registrant
- June 16, 2025 (date) — Date of earliest event reported
- June 18, 2025 (date) — Filing date
FAQ
What is the nature of the material definitive agreement entered into by Adial Pharmaceuticals?
The filing states that Adial Pharmaceuticals, Inc. entered into a material definitive agreement on June 16, 2025, but the specific terms and details of this agreement are not disclosed in this particular 8-K filing.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on June 18, 2025.
What is Adial Pharmaceuticals' principal business address?
Adial Pharmaceuticals' principal business address is 4870 Sadler Road, Ste 300, Glen Allen, VA 23060.
What is Adial Pharmaceuticals' state of incorporation?
Adial Pharmaceuticals, Inc. is incorporated in Delaware.
What is the SIC code for Adial Pharmaceuticals?
The Standard Industrial Classification (SIC) code for Adial Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding ADIAL PHARMACEUTICALS, INC. (ADIL).